Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.
Dimitrios A PappasJacqueline O'BrienPage C MooreRhiannon DodgeRebecca GerminoKarim Richard MasriClifton O BinghamLaura C CappelliPublished in: The Journal of rheumatology (2024)
TOF effectiveness (CDAI LDA) was observed in a US real-world setting of patients with RA regardless of TOF regimen, line of therapy, time of initiation, and dose. (ClinicalTrials.gov: NCT04721808).
Keyphrases
- rheumatoid arthritis
- disease activity
- mass spectrometry
- end stage renal disease
- randomized controlled trial
- ms ms
- systematic review
- ankylosing spondylitis
- interstitial lung disease
- chronic kidney disease
- ejection fraction
- stem cells
- systemic lupus erythematosus
- peritoneal dialysis
- mesenchymal stem cells
- patient reported outcomes
- bone marrow
- systemic sclerosis
- ulcerative colitis
- combination therapy